Huafeng Zhou

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Ruben A. Mesa, Alessandro M. Vannucchi, Adam J. Mead et al. · The Lancet Haematology · 2017 · 300 citations · Full text

Hematological Malignancy, Oncology, Pacritinib Versus +9

Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial

Ganesh Raghu, David A. Lynch, J. David Godwin et al. · The Lancet Respiratory Medicine · 2014 · 185 citations

Medical Imaging, Advanced Lung Disease, Idiopathic Pulmonary Fibrosis +9

Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction

Ganesh Raghu, Steven D. Nathan, Jürgen Behr et al. · European Respiratory Journal · 2015 · 160 citations

Hypertension, Heart Failure, World Health Organization +16

Honeycomb-like bamboo powders-derived porous carbon with low filler loading, high-performance microwave absorption

Zhihong Wu, Jijin Chang, Xinyu Guo et al. · Carbon · 2023 · 103 citations

Materials Science, Materials Engineering, Chemical Engineering +7

Healthy Behavior Change of Adults With Mental Retardation: Attendance in a Health Promotion Program

Joshua R. Mann, Huafeng Zhou, Suzanne McDermott et al. · American Journal on Mental Retardation · 2005 · 95 citations

Physical Activity, Disability, Mental Health Intervention +19